Ambrx Competitors and Similar CompaniesClear all

Ambrx's competitors and similar companies include Pharming Group and ProQR Therapeutics.

	Ambrx Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code.	Pharming Group Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.	ProQR Therapeutics ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases.
Founding Date	Founding Date 2003	Founding Date 1988	Founding Date 2012
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech genetics pharma therapy
Locations	Locations San Diego, US HQ	Locations Leiden, NL HQ Leiden, NL	Locations Leiden, NL HQ Cambridge, US
Employees	Employees 70	Employees 404	Employees 166
Valuation ($)	Valuation ($) 1.8 b	Valuation ($) 590.3 m	Valuation ($) 281.8 m
Financial
Revenue (est.)	Revenue (est.) $7.4m (FY, 2022)	Revenue (est.) $376.1m (FY, 2025)	Revenue (est.) €15.9m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $41.6m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $341m (FY, 2025)	Gross profit €16.3m (FY, 2025)
Net income	Net income ($78m) (FY, 2022)	Net income $2.5m (FY, 2025)	Net income (€42.2m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 347.9m	Total funding raised N/A	Total funding raised $ 57.8m